Amylyx Pharmaceuticals, Inc. AMLX Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s change in AP?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported change in AP of $10K in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s change in AP changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s change in AP decreased by 99.5% year-over-year, from $1.87M to $10K.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.